ArticleFrontiers in cardiovascular medicine2026
Associations of AI-derived coronary CT angiography features with CZT-SPECT coronary flow reserve and FFR-CT.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to explore the associations of artificial intelligence (AI)-derived coronary CT angiography (CCTA) features with coronary flow reserve (CFR) measured by cardiac-cadmium zinc-telluride single-photon emission computed tomography (CZT-SPECT) and CT-derived fractional flow reserve (FFR-CT), and to investigate their intrinsic relationships. Methods: This retrospective study included 251 patients (753 vessels) with suspected or known coronary artery disease (CAD), who underwent CZT-SPECT and concurrent CCTA. Myocardial ischemia was defined as CFR <2.0 or FFR-CT ≤0.8. Generalized estimating equations (GEE) were used to analyze the associations between CCTA coronary parameters and the two ischemia definitions. Results: Among the 753 vessels, the agreement analysis between CFR and FFR-CT for ischemia was poor (Kappa = 0.084). Multivariate analysis demonstrated that CFR <2.0 was only associated with perivascular fat attenuation index (FAI) and calcified plaque burden, whereas FFR-CT ≤0.8 was additionally predicted by low attenuation plaque and lipid plaque burden (all Conclusions: CFR and FFR-CT reflect different pathophysiological dimensions: CFR reduction is more associated with microvascular dysfunction in the context of inflammation and diffuse lesions, whereas FFR-CT mainly reflects focal, obstructive ischemia caused by high-risk plaques (such as low attenuation plaque). CCTA is an important tool for assessing obstructive coronary lesions, but coronary features alone are insufficient to predict whether CFR is abnormal or not. However, in the absence of invasive reference standards (invasive FFR and index of microcirculatory resistance), these findings should be considered hypothesis-generating and require confirmation in future studies incorporating invasive physiological assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.